SEC Form 13F
| Report period | 2025-09-30 |
|---|---|
| Publicly available | 2025-11-15 |
| Reported value | $43,047,844 |
| Positions | 7 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| EWTX | EWTX | EDGEWISE THERAPEUTICS INC | $16,709,211 | 1,030,161 |
| ARVN | ARVN | ARVINAS INC | $13,510,343 | 1,585,721 |
| CRNX | CRNX | CRINETICS PHARMACEUTICALS INC | $5,872,650 | 141,000 |
| COGT | COGT | COGENT BIOSCIENCES INC. | $3,600,985 | 250,765 |
| RLYB | Unresolved | RALLYBIO CORPORATION | $1,647,500 | 3,301,603 |
| ALEC | ALEC | ALECTOR INC | $1,005,124 | 339,569 |
| PASG | Unresolved | PASSAGE BIO | $702,031 | 87,426 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.